Suppliers and packages for generic ingredient: lamivudine
✉ Email this page to a colleague
lamivudine
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | EPIVIR | lamivudine | TABLET;ORAL | 020564 | NDA | ViiV Healthcare Company | 49702-203-18 | 60 TABLET, FILM COATED in 1 BOTTLE (49702-203-18) | 2010-10-04 |
| Viiv Hlthcare | EPIVIR | lamivudine | TABLET;ORAL | 020564 | NDA | ViiV Healthcare Company | 49702-204-13 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13) | 2010-10-04 |
| Viiv Hlthcare | EPIVIR | lamivudine | SOLUTION;ORAL | 020596 | NDA | ViiV Healthcare Company | 49702-205-48 | 240 mL in 1 BOTTLE (49702-205-48) | 2010-10-04 |
| Glaxosmithkline | EPIVIR-HBV | lamivudine | TABLET;ORAL | 021003 | NDA | GlaxoSmithKline LLC | 0173-0662-00 | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0662-00) | 1998-12-17 |
| Glaxosmithkline | EPIVIR-HBV | lamivudine | TABLET;ORAL | 021003 | NDA AUTHORIZED GENERIC | Prasco Laboratories | 66993-478-60 | 60 TABLET, FILM COATED in 1 BOTTLE (66993-478-60) | 2014-09-05 |
| Glaxosmithkline | EPIVIR-HBV | lamivudine | SOLUTION;ORAL | 021004 | NDA | GlaxoSmithKline LLC | 0173-0663-00 | 240 mL in 1 BOTTLE (0173-0663-00) | 1998-12-23 |
| Cipla | LAMIVUDINE | lamivudine | TABLET;ORAL | 077221 | ANDA | Cipla USA Inc. | 69097-166-03 | 60 TABLET in 1 BOTTLE (69097-166-03) | 2017-03-03 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
